Heparin resistance

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Supportive / diluent 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Octapharma AG Commercial
    ANTITHROMBIN III HUMAN; SODIUM CHLORIDE
    2023-507560-39-00 8 countries 2025 n=53
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Octapharma AG Commercial 1 Phase III 1
New trials by year
2025
1
← All indication landscapes